non glp 1 GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 gastric balloon Non-GLP-1 Weight Loss Medications Explained
Description
For people whose hair loss is driven by insulin resistance and metabolic dysfunction, tirzepatide may actually help rather than harm
Congress could change this in the future, and some organizations are working to get it passed
Both compounds produce clinically significant weight loss
Quick Answer: Sulphur burps during GLP-1 therapy occur because these medicines slow gastric emptying, allowing increased bacterial fermentation of sulphur-containing proteins in the digestive tract, which produces hydrogen sulphide gas
GLP-1 agonists have evolved considerably in the last two decades
